Usa Financial Portformulas Corp Corcept Therapeutics Inc Transaction History

Usa Financial Portformulas Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 06, 2021	SELL	$23.49 - $30.56 $56,399 - $73,374	-2,401 Closed	0 $0
Q4 2020 Jan 29, 2021	BUY	$16.78 - $27.3 $40,288 - $65,547	2,401 New	2,401 $63,000
Q3 2020 Oct 09, 2020	SELL	$12.46 - $19.98 $219,370 - $351,767	-17,606 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$11.0 - $18.26 $193,666 - $321,485	17,606 New	17,606 $296,000
Q4 2017 Feb 13, 2018	SELL	$15.77 - $20.72 $537,615 - $706,365	-34,091 Closed	0 $0
Q3 2017 Oct 11, 2017	BUY	$12.3 - $19.3 $419,319 - $657,956	34,091	34,091 $658,000

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.3B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Usa Financial Portformulas Corp, based on Form 13F filings with the SEC.

Stay updated on Usa Financial Portformulas Corp with notifications on news.